Bill · H.R. 8651· House(119-HR-8651)
Advancing Safe Medications for Moms and Babies Act of 2026
- Introduced
- 5/4/2026
- Last activity
- 5/4/2026 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- Kathy Castor
- Cosponsors
- - 1 - 1
- Introduced
- In Committee
What this bill would do
The Advancing Safe Medications for Moms and Babies Act of 2026 aims to increase the inclusion of pregnant and lactating women in clinical research. It directs the FDA to harmonize regulations to better protect and include these women in research studies. The bill also requires an education campaign to inform patients and providers about the benefits of research and how to find clinical trials. Additionally, the NIH is tasked with prioritizing research projects specifically concerning drugs used by pregnant and lactating women. This includes establishing a process to fund research based on medical needs and disease severity.
Yes· 3 of 7
Would women be better off under this?+6
The bill directly benefits women by promoting their inclusion in clinical research and addressing their specific medical needs.
Does this put more money into medical research?+6
The bill authorizes specific funding for the NICHD to carry out priority research projects concerning drugs used by pregnant and lactating women.
Does this put more money into scientific research?+6
The bill mandates priority research projects through the NICHD to address unmet medical needs in pregnant and lactating populations.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased Inclusion in Research: The bill seeks to promote the inclusion of pregnant women in clinical research and harmonize FDA regulations to facilitate this (Section 2).
-
Improved Health Awareness: An education campaign will teach patients, families, and healthcare providers how including pregnant and lactating women in research can benefit maternal and infant health (Section 3(a)(1)).
-
Better Access to Information: The Secretary will create a public website with a user-friendly interface to help people find clinical trials and registries involving pregnant and lactating women (Section 3(d)).
-
Targeted Research Funding: The NICHD will carry out priority research projects on drugs prescribed for pregnant and lactating women, focusing on unmet medical needs and the severity of conditions (Section 4(a) and Section 4(b)).
Potential Negative Impacts for People
- No specific negative impacts or burdens are explicitly stated in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Women+6Good For Children+5
- Healthcare
- Increases Research Funding+6Improves Healthcare Access+5
- Education And Technology
- Increases Scientific Research Funding+6
- Social Issues And Justice
- Improves Gender Equality+5
- Governance And Ideology
- Improves Government Transparency+3
- 5/4/2026
- Referred to the House Committee on Energy and Commerce.
- 2 Cosponsors added.
- Introduced in House
Brian FitzpatrickRepublican · Pennsylvania
Lauren UnderwoodDemocrat · Illinois